Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
University of California, Irvine
Cedars-Sinai Medical Center
Indiana University
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
RenJi Hospital
M.D. Anderson Cancer Center
The Netherlands Cancer Institute
Queen Mary University of London
University of California, San Francisco
British Columbia Cancer Agency
Dana-Farber Cancer Institute
Milton S. Hershey Medical Center
Ottawa Hospital Research Institute
University of California, Irvine
Stanford University
Algemeen Ziekenhuis Maria Middelares
Sharp HealthCare
University Teaching Hospital Hall in Tirol
University of Toronto
Mayo Clinic
Universitaire Ziekenhuizen KU Leuven
Milton S. Hershey Medical Center
Steba Biotech S.A.
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Kaiser Permanente
Massachusetts General Hospital
Mayo Clinic
Region Skane
City of Hope Medical Center
Medipol University
British Columbia Cancer Agency
Tianjin Medical University Second Hospital
RenJi Hospital
Women's College Hospital
Herlev and Gentofte Hospital
Steba Biotech S.A.
Jiangsu Cancer Institute & Hospital
Tampere University Hospital
Azienda Ospedaliero-Universitaria di Modena
KU Leuven
M.D. Anderson Cancer Center
Virginia Commonwealth University
Steba Biotech S.A.
Cedars-Sinai Medical Center
University of Toronto